RYTM - RHYTHM PHARMACEUTICALS, INC.


91.46
0.460   0.503%

Share volume: 661,337
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%

$91.00
0.46
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-06-2024 11-06-2024 02-28-2025 05-07-2025 08-05-2025 11-04-2025 02-26-2026
Total revenue 25.967 M 29.078 M 33.251 M 41.830 M 32.704 M 48.502 M 51.298 M 57.253 M
Cost of revenue 2.807 M 2.947 M 3.828 M 3.786 M 3.648 M 5.543 M 5.499 M 4.802 M
Gross profit 23.160 M 26.131 M 29.423 M 38.044 M 29.056 M 42.959 M 45.799 M 52.451 M
    12.83% 12.60% 29.30% -23.63% 47.85% 6.61% 14.52%  
Operating expenses 163.047 M 66.609 M 73.308 M 79.297 M 76.060 M 88.255 M 98.452 M 99.514 M
Selling general and admin 34.382 M 36.415 M 35.377 M 38.130 M 39.087 M 45.947 M 52.425 M 57.482 M
Research and development 128.665 M 30.194 M 37.931 M 41.167 M 36.973 M 42.308 M 46.027 M 42.032 M
Total expenses 165.854 M 66.609 M 73.308 M 79.297 M 76.060 M 88.255 M 98.452 M 99.514 M
    -59.84% 10.06% 8.17% -4.08% 16.03% 11.55% 1.08%  
Operating income -139.887 M -40.478 M -43.885 M -41.253 M -47.004 M -45.296 M -52.653 M -47.063 M
Ebit -139.887 M -31.276 M -42.797 M -43.167 M -47.648 M -43.720 M -52.379 M -47.005 M
Pretax income -141.072 M -31.782 M -43.985 M -43.417 M -49.418 M -46.295 M -52.793 M -47.536 M
    -77.47% 38.40% -1.29% 13.82% -6.32% 14.04% -9.96%  
Income tax 300.000 K 479.000 K -344.000 K -89.000 K 80.000 K 337.000 K 111.000 K -31.000 K
Net income basic -141.372 M 0.000 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%              
Net income -141.372 M -32.261 M -43.641 M -43.328 M -49.498 M -46.632 M -52.904 M -47.505 M
    77.18% -35.27% 0.72% -14.24% 5.79% -13.45% 10.21%